Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status

BACKGROUND: Phase III, open-label, single-center, controlled study in South Africa (ClinicalTrials.gov: NCT00829010) to evaluate immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in human immunodeficienc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Madhi, Shabir A., Koen, Anthonet, Jose, Lisa, van Niekerk, Nadia, Adrian, Peter V., Cutland, Clare, François, Nancy, Ruiz-Guiñazú, Javier, Yarzabal, Juan-Pablo, Moreira, Marta, Borys, Dorota, Schuerman, Lode
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2017
Assuntos:
4850
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5266190/
https://ncbi.nlm.nih.gov/pubmed/28079828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000005881
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados